Skip to content

Efficacy of Folrex in the Superior Extremity Rehabilitation After Acute Stroke

Efficacy of Folrex in the Superior Extremity Rehabilitation After Acute Stroke

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01016119
Enrollment
40
Registered
2009-11-18
Start date
2009-10-31
Completion date
2010-03-31
Last updated
2010-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

The purpose of the study is to evaluate whether Folrex, could improve the motor recovery of the upper extremity after stroke in comparison with placebo during 4 weeks of treatment.

Detailed description

Periodical measures of the motor recovery, of the upper extremity, by Fugl-Meyer score, it will be done at the beginning, at fifth day and at month. Each value will be compare to evaluate whether the groups of patient improve.

Interventions

DRUGFolrex

Folrex cream, in the early rehabilitations in the upper extremity, before daily rehabilitation

DRUGPlacebo

Placebo cream, in the early rehabilitations in the upper extremity, before daily rehabilitation

Sponsors

Catalysis SL
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients with acute stroke \< 24 hours. * Patients with impairment up to 4 on NIHSS scale. * Family support. * Informed consent.

Exclusion criteria

* Presence of another disease not well controlled. * Patient with dementia.

Design outcomes

Primary

MeasureTime frame
Periodical measures of the motor recovery, of the upper extremity, by Fugl-Meyer score, it will be done at the beginning, at fifth day and at month (4 weeks).4 weeks

Secondary

MeasureTime frame
Barthel index4 weeks
National Institutes of Health Stroke Scale (NIHSS)4 weeks

Countries

Cuba

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026